Literature DB >> 21037875

Issues surrounding biospecimen collection and use in clinical trials.

Allison R Baer1, Mary Lou Smith, Deborah Collyar, Jeffrey Peppercorn.   

Abstract

As the need for patient participation in biospecimen and correlative research increases, challenging ethical and potentially legal questions are emerging.

Entities:  

Year:  2010        PMID： 21037875      PMCID： PMC2900874          DOI： 10.1200/JOP.777004

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  4 in total

Review 1.  Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group.

Authors:  D C Anderson; B Gomez-Mancilla; B B Spear; D M Barnes; K Cheeseman; P M Shaw; J Friedman; A McCarthy; C Brazell; S C Ray; D McHale; L Hashimoto; R Sandbrink; M L Watson; R A Salerno; N Cohen; C E Lister
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

2.  A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program.

Authors:  John F Scoggins; Scott D Ramsey
Journal:  J Natl Cancer Inst       Date:  2010-08-03       Impact factor: 13.506

Review 3.  Returning genetic research results to individuals: points-to-consider.

Authors:  Gaile Renegar; Christopher J Webster; Steffen Stuerzebecher; Lea Harty; Susan E Ide; Beth Balkite; Taryn A Rogalski-Salter; Nadine Cohen; Brian B Spear; Diane M Barnes; Celia Brazell
Journal:  Bioethics       Date:  2006-02       Impact factor: 1.898

4.  American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.

Authors:  Robin Zon; Neal J Meropol; Robert B Catalano; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2008-04-07       Impact factor: 44.544
  4 in total
  5 in total

1.  Considerations for bio-specimen collection among black women residing in the rural Deep South participating in a cancer prevention study.

Authors:  Tiffany L Carson; Claudia M Hardy; Eva Greene; Pamela L Carter; Glenda James; Edward E Partridge; Monica L Baskin
Journal:  J Community Genet       Date:  2013-12-15

2.  Development and validation of the biobanking attitudes and knowledge survey-Spanish (BANKS-SP).

Authors:  Mariana Arevalo; Paul B Jacobsen; Clement K Gwede; Cathy D Meade; Gwendolyn P Quinn; John S Luque; Gloria San Miguel; Dale Watson; Kristen J Wells
Journal:  J Community Genet       Date:  2016-09-15

3.  Development and validation of the biobanking attitudes and knowledge survey (BANKS).

Authors:  Kristen J Wells; Mariana Arevalo; Cathy D Meade; Clement K Gwede; Gwendolyn P Quinn; John S Luque; Gloria San Miguel; Dale Watson; Rebecca Phillips; Carmen Reyes; Margarita Romo; Jim West; Paul B Jacobsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03       Impact factor: 4.254

4.  Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance).

Authors:  Lynn G Dressler; Allison M Deal; Kouros Owzar; Dorothy Watson; Katherine Donahue; Paula N Friedman; Mark J Ratain; Howard L McLeod
Journal:  J Natl Cancer Inst       Date:  2015-07-09       Impact factor: 13.506

5.  Patients' willingness to participate in a breast cancer biobank at screening mammogram.

Authors:  Christoph I Lee; Lawrence W Bassett; Mei Leng; Sally L Maliski; Bryan B Pezeshki; Colin J Wells; Carol M Mangione; Arash Naeim
Journal:  Breast Cancer Res Treat       Date:  2012-11-06       Impact factor: 4.872
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.